Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 41

1.

Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials.

O'Donoghue ML, Braunwald E, Antman EM, Murphy SA, Bates ER, Rozenman Y, Michelson AD, Hautvast RW, Ver Lee PN, Close SL, Shen L, Mega JL, Sabatine MS, Wiviott SD.

Lancet. 2009 Sep 19;374(9694):989-97. doi: 10.1016/S0140-6736(09)61525-7. Epub 2009 Aug 31. Review.

PMID:
19726078
2.

An algorithm to identify incident myocardial infarction using Medicaid data.

Choma NN, Griffin MR, Huang RL, Mitchel EF Jr, Kaltenbach LA, Gideon P, Stratton SM, Roumie CL.

Pharmacoepidemiol Drug Saf. 2009 Nov;18(11):1064-71. doi: 10.1002/pds.1821.

PMID:
19718697
3.

Adverse outcomes associated with use of proton pump inhibitors and clopidogrel.

Chae YK, Kim J.

JAMA. 2009 Jul 1;302(1):29; author reply 31. doi: 10.1001/jama.2009.896. No abstract available.

PMID:
19567430
4.

Adverse outcomes associated with use of proton pump inhibitors and clopidogrel.

Schneider-Lindner V, Filion KB, Brophy JM.

JAMA. 2009 Jul 1;302(1):29-30; author reply 31. doi: 10.1001/jama.2009.897. No abstract available.

PMID:
19567429
5.

Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome.

Ho PM, Maddox TM, Wang L, Fihn SD, Jesse RL, Peterson ED, Rumsfeld JS.

JAMA. 2009 Mar 4;301(9):937-44. doi: 10.1001/jama.2009.261.

PMID:
19258584
6.

A population-based study of the drug interaction between proton pump inhibitors and clopidogrel.

Juurlink DN, Gomes T, Ko DT, Szmitko PE, Austin PC, Tu JV, Henry DA, Kopp A, Mamdani MM.

CMAJ. 2009 Mar 31;180(7):713-8. doi: 10.1503/cmaj.082001. Epub 2009 Jan 28.

7.

Clopidogrel, genetics, and drug responsiveness.

Freedman JE, Hylek EM.

N Engl J Med. 2009 Jan 22;360(4):411-3. doi: 10.1056/NEJMe0810513. No abstract available.

PMID:
19164193
8.

Atypical antipsychotic drugs and the risk of sudden cardiac death.

Ray WA, Chung CP, Murray KT, Hall K, Stein CM.

N Engl J Med. 2009 Jan 15;360(3):225-35. doi: 10.1056/NEJMoa0806994. Erratum in: N Engl J Med. 2009 Oct 29;361(18):1814.

9.

Cytochrome p-450 polymorphisms and response to clopidogrel.

Mega JL, Close SL, Wiviott SD, Shen L, Hockett RD, Brandt JT, Walker JR, Antman EM, Macias W, Braunwald E, Sabatine MS.

N Engl J Med. 2009 Jan 22;360(4):354-62. doi: 10.1056/NEJMoa0809171. Epub 2008 Dec 22.

10.

Genetic determinants of response to clopidogrel and cardiovascular events.

Simon T, Verstuyft C, Mary-Krause M, Quteineh L, Drouet E, Méneveau N, Steg PG, Ferrières J, Danchin N, Becquemont L; French Registry of Acute ST-Elevation and Non-ST-Elevation Myocardial Infarction (FAST-MI) Investigators..

N Engl J Med. 2009 Jan 22;360(4):363-75. doi: 10.1056/NEJMoa0808227. Epub 2008 Dec 22.

11.

Effects of pantoprazole and esomeprazole on platelet inhibition by clopidogrel.

Siller-Matula JM, Spiel AO, Lang IM, Kreiner G, Christ G, Jilma B.

Am Heart J. 2009 Jan;157(1):148.e1-5. doi: 10.1016/j.ahj.2008.09.017. Epub 2008 Nov 6.

PMID:
19081411
12.

ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents.

Bhatt DL, Scheiman J, Abraham NS, Antman EM, Chan FK, Furberg CD, Johnson DA, Mahaffey KW, Quigley EM, Harrington RA, Bates ER, Bridges CR, Eisenberg MJ, Ferrari VA, Hlatky MA, Kaul S, Lindner JR, Moliterno DJ, Mukherjee D, Schofield RS, Rosenson RS, Stein JH, Weitz HH, Wesley DJ; American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents..

J Am Coll Cardiol. 2008 Oct 28;52(18):1502-17. doi: 10.1016/j.jacc.2008.08.002. No abstract available.

13.

Clinical practice. Gastroesophageal reflux disease.

Kahrilas PJ.

N Engl J Med. 2008 Oct 16;359(16):1700-7. doi: 10.1056/NEJMcp0804684. Review. No abstract available.

14.

Effects of the proton pump inhibitor lansoprazole on the pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel.

Small DS, Farid NA, Payne CD, Weerakkody GJ, Li YG, Brandt JT, Salazar DE, Winters KJ.

J Clin Pharmacol. 2008 Apr;48(4):475-84. doi: 10.1177/0091270008315310. Epub 2008 Feb 26.

PMID:
18303127
15.

Omeprazole: a possible new candidate influencing the antiplatelet effect of clopidogrel.

Gurbel PA, Lau WC, Tantry US.

J Am Coll Cardiol. 2008 Jan 22;51(3):261-3. doi: 10.1016/j.jacc.2007.07.090. No abstract available.

16.

Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study.

Gilard M, Arnaud B, Cornily JC, Le Gal G, Lacut K, Le Calvez G, Mansourati J, Mottier D, Abgrall JF, Boschat J.

J Am Coll Cardiol. 2008 Jan 22;51(3):256-60. doi: 10.1016/j.jacc.2007.06.064.

17.

Prasugrel versus clopidogrel in patients with acute coronary syndromes.

Wiviott SD, Braunwald E, McCabe CH, Montalescot G, Ruzyllo W, Gottlieb S, Neumann FJ, Ardissino D, De Servi S, Murphy SA, Riesmeyer J, Weerakkody G, Gibson CM, Antman EM; TRITON-TIMI 38 Investigators..

N Engl J Med. 2007 Nov 15;357(20):2001-15. Epub 2007 Nov 4.

18.

Validation of ICD-9 codes with a high positive predictive value for incident strokes resulting in hospitalization using Medicaid health data.

Roumie CL, Mitchel E, Gideon PS, Varas-Lorenzo C, Castellsague J, Griffin MR.

Pharmacoepidemiol Drug Saf. 2008 Jan;17(1):20-6.

PMID:
17979142
19.

Risk of peptic ulcer hospitalizations in users of NSAIDs with gastroprotective cotherapy versus coxibs.

Ray WA, Chung CP, Stein CM, Smalley WE, Hall K, Arbogast PG, Griffin MR.

Gastroenterology. 2007 Sep;133(3):790-8. Epub 2007 Jul 3.

PMID:
17854591
20.

Predictive and protective factors associated with upper gastrointestinal bleeding after percutaneous coronary intervention: a case-control study.

Chin MW, Yong G, Bulsara MK, Rankin J, Forbes GM.

Am J Gastroenterol. 2007 Nov;102(11):2411-6. Epub 2007 Sep 10.

PMID:
17850413

Supplemental Content

Support Center